Journal of the Chinese Medical Association
Volume 69, Issue 6 , Pages 259-263, June 2006

Single-dose Sertaconazole Vaginal Tablet Treatment of Vulvovaginal Candidiasis

  • Peng-Hui Wang

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, National Yang-Ming University, Taipei, Taiwan, R.O.C.
    • Institute of Emergency and Critical Care Medicine, National Yang-Ming University, Taipei, Taiwan, R.O.C.
    • Corresponding Author InformationCorrespondence to: Dr. Peng-Hui Wang, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C.
    • ,
  • Hsiang-Tai Chao

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, National Yang-Ming University, Taipei, Taiwan, R.O.C.
    • ,
  • Cheng-Li Chen

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan, R.O.C.
    • ,
  • Chiou-Chung Yuan

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, National Yang-Ming University, Taipei, Taiwan, R.O.C.

Received 30 September 2005; accepted 11 April 2006.

Article Outline

Background

Vulvovaginal candidiasis (VVC) is a bothersome disease in women. Poor compliance with the continuous use of antifungal vaginal drugs often results in treatment failure. The aim of the present study was to evaluate the efficacy, acceptability, and safety of single-dose sertaconazole vaginal tablet (500 mg) treatment compared with conventional 3-dose econazole vaginal tablet (150 mg) treatment for VVC.

Methods

In this open, randomized, and comparative study, 40 symptomatic patients with VVC confirmed by the smear method were enrolled. Patients in group A were treated with single-dose sertaconazole vaginal tablet and those in group B were treated continuously with econazole vaginal tablet for 3 days.

Results

The characteristics of the patients in both groups were comparable and without statistical difference. Group A showed a significantly better clearance rate for candidiasis than group B (100% vs. 72.2% on day 7, p = 0.013; 100% vs. 77.8% on day 14, p = 0.030), based on smear method results. Group A showed a more rapid response for symptom relief than group B on day 7, but there was no difference in overall symptom relief between group A and group B on day 14.

Conclusion

Single-dose sertaconazole proved to be a more convenient and symptom-relieving treatment for VVC. The advantages of such management are worthy of further study in women with relapse VVC.

Key Words:  econazole , sertaconazole , vulvovaginal candidiasis

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Egan M , Lipsky MS . Vaginitis: case reports and brief review . AIDS Patient Care STDS . 2002;16:367–373
  2. Kent HL . Epidemiology of vaginitis . Am J Obstet Gynecol . 1991;165:1168–1176
  3. Kinghorn GR . Vulvovaginal candidosis . J Antimicrob Chemother . 1991;28:59–66
  4. Garcfa JF , Scheneider J , Ponton J . Vulvovaginitis candidiasica . Med Clin (Barc) . 1994;103:505–508
  5. Horowitz BJ . Mycotic vulvovaginitis: a broad overview . Am J Obstet Gynecol . 1991;165:1188–1192
  6. Horowitz BJ , Diane G , Ito S . Evolving pathogens in vulvovaginal candidiasis: implications for patient care . J Clin Pharmacol . 1992;32:248–255
  7. Ries AJ . Treatment of vaginal infections: candidiasis, bacterial vaginosis, and trichomoniasis . J Am Pharm Assoc . 1997;37:563–569
  8. Faro S . Systemic vs. topical therapy for the treatment of vulvo-vaginal candidiasis . Infect Dis Obstet Gynecol . 1994;1:202–208
  9. McCue JD . Evaluation and management of vaginitis: an update for primary care practitioners . Arch Intern Med . 1989;149:565–568
  10. Reed BD , Eyler A . Vaginal infections: diagnosis and management . Am Fam Phys . 1993;47:1805–1818
  11. Raga MM , Moreno-Manas M , Cuberes MR , Palacin C , Castello JM , Ortiz JA . Synthesis and antimycotic activity of (benzo[b] thienyl)methyl ethers of 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-ethanol and of (Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone oxime . Arzneimittelforschung . 1992;42:691–694
  12. Agut J , Palacin C , Sacristan A , Ortiz JA . Inhibition of ergo-sterol synthesis by sertaconazole in Candida albicans . Arzneimittelforschung . 1992;42:718–720
  13. Agut J , Palacin C , Salgado J , Casas E , Sacristan A , Ortiz JA . Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity . Arzneimittelforschung . 1992;42:721–724
  14. Palacin C , Sacristan A , Ortiz JA . In vitro activity of sertaconazole . Arzneimittelforschung . 1992;42:699–705
  15. Edwards L . The diagnosis and treatment of infectious vaginitis . Dermatol Ther . 2004;17:102–110
  16. De Vos MM, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T, et al  Vulvovaginal candidiasis in a Flemish patient population . Clin Microbiol Infect . 2005;11:1005–1011
  17. Martens MG , Hoffman P , El-Zaatari M . Fungal species changes in the female genital tract . J Low Genit Tract Dis . 2004;8:21–24
  18. Giraldo P , von Nowaskonski A , Gomes FA , Linhares I , Neves NA , Witkin SS . Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis . Obstet Gynecol . 2000;95:413–416
  19. Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al  Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis . N Engl J Med . 2004;351:876–883
  20. Torres J , Marquez M , Camps F . Sertaconazole in the treatment of mycoses: from dermatology to gynecology . Int J Gynecol Obstet . 2000;71:3–20
  21. Palacin C , Sacristan A , Ortiz JA . In vivo activity of serta-conazole in experimental dermatophytosis in guinea pigs . Arzneimittelforschung . 1992;42:714–718
  22. Dellenbach P , Thomas JL , Guerin V , Oshsenbein E , Contet-Audonneau N . Topical treatment of vaginal candidiasis with sertaconazole and econazole sustained-release suppositories . Int J Gynecol Obstet . 2000;71:47–52
  23. Palacin C , Tarrago C , Ortiz JA . Sertaconazole: pharmacology of a gynecological antifungal agent . Int J Gynecol Obstet . 2000;71:37–46
  24. Palacin C , Sacristan A , Ortiz JA . In vivo activity of sertaconazole in experimental candidiasis in the mouse . Drugs Expl Clin Res . 1990;16:469–473

PII: S1726-4901(09)70253-9

doi:10.1016/S1726-4901(09)70253-9

Journal of the Chinese Medical Association
Volume 69, Issue 6 , Pages 259-263, June 2006

Article Tools